ArticleJournal of autoimmunity2019

Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II:peptide complex modulate the progression of autoimmune diabetes.

Li Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.